As shown in Figure 6G, the A549 tumour-induced expression of skeletal muscle atrophy-related genes, such as Mstn, Fbxo32, and Trim63 was mitigated upon treatment with 2% Pc-Ex. This evidence concerns the gene MSTN and neoplasm.